European Society of Toxicology In Vitro > News > The Final ASPIS Open Symposium: From Innovation to Regulatory Impact
26 February 2026

The Final ASPIS Open Symposium: From Innovation to Regulatory Impact

The Final ASPIS Open Symposium will take place on 2–3 July 2026 in Maastricht, the Netherlands, as a satellite event of the ESTIV 2026 Congress. This closing edition marks the culmination of five years of collaboration across the ASPIS cluster and shifts the focus firmly toward impact.

Bringing together scientists, regulators, industry representatives and policy stakeholders, the Symposium will concentrate on one central question: how can the scientific advances achieved by ASPIS translate into lasting change in chemical safety assessment?

Over the past five years, the three Horizon 2020 projects — ONTOXPrecisionTox, and RISK-HUNT3R — have developed innovative, animal-free approaches that combine advanced biological methods, computational tools, and AI-enabled systems. With the projects concluding in 2026, the emphasis now turns to regulatory uptake, long-term accessibility of tools and data, and sustained collaboration beyond EU funding.

“The Final Symposium is both a celebration and a responsibility. Our priority is to ensure that ASPIS results move beyond research and become embedded in regulatory practice, supporting ethical and human-relevant chemical safety assessment,” says Prof. Mathieu Vinken, ASPIS Cluster Coordinator (2024–2026).

Four Sessions Framing the Transition

The programme will focus on:

  • Research & Innovation – key scientific achievements across the three projects
  • Regulatory Translation & Implementation – practical integration of ASPIS tools into decision-making
  • Impact & Sustainability – ensuring long-term availability of data, platforms and expertise
  • ASPIS Academy – empowering the next generation of scientists

Learn more and register here: https://www.estiv.org/congress2026/post-congress-ws-aspis-open-symposium/

Related content

Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment

  • News

ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.

ESTIV 2026 LAST-MINUTE ABSTRACT SUBMISSION OPEN

We are pleased to announce that last‑minute poster abstract submissions are now open.

Researchers who still wish to contribute are warmly invited to submit their work. The deadline for last‑minute submissions is 8 May 2026 at 23:59 CET.

ESTIV-ASCCT:  Award Winners Series: AI & Machine Learning

Check out the details on the next installment of our ESTIV – ASCCT Award Winners Webinar and make sure to register if you haven’t already. We hope to see you there!

Silver Sponsor

Communication partners

Memorandum of Understanding